|
Clinical Trials and Observations
Citations 61-70 of 2742 total displayed.
|
Past content
(since May 1998):
|
Insertion of FLT3 internal tandem duplication in the tyrosine kinase domain-1 is associated with resistance to chemotherapy and inferior outcome
- Sabine Kayser, Richard F. Schlenk, Martina Correa Londono, Frank Breitenbuecher, Kerstin Wittke, Juan Du, Silja Groner, Daniela Späth, Jürgen Krauter, Arnold Ganser, Hartmut Döhner, Thomas Fischer, Konstanze Döhner, and for the German-Austrian AML Study Group (AMLSG)
Blood 2009; 114: 2386-2392.
[Abstract]
[Full text]
[PDF]
Treatment of myelodysplastic syndrome patients with erythropoietin with or without granulocyte colony-stimulating factor: results of a prospective randomized phase 3 trial by the Eastern Cooperative Oncology Group (E1996)
- Peter L. Greenberg, Zhuoxin Sun, Kenneth B. Miller, John M. Bennett, Martin S. Tallman, Gordon Dewald, Elisabeth Paietta, Richard van der Jagt, Jessie Houston, Mary L. Thomas, David Cella, and Jacob M. Rowe
Blood 2009; 114: 2393-2400.
[Abstract]
[Full text]
[PDF]
Novel prognostic subgroups in childhood 11q23/MLL-rearranged acute myeloid leukemia: results of an international retrospective study
- Brian V. Balgobind, Susana C. Raimondi, Jochen Harbott, Martin Zimmermann, Todd A. Alonzo, Anne Auvrignon, H. Berna Beverloo, Myron Chang, Ursula Creutzig, Michael N. Dworzak, Erik Forestier, Brenda Gibson, Henrik Hasle, Christine J. Harrison, Nyla A. Heerema, Gertjan J. L. Kaspers, Anna Leszl, Nathalia Litvinko, Luca Lo Nigro, Akira Morimoto, Christine Perot, Rob Pieters, Dirk Reinhardt, Jeffrey E. Rubnitz, Franklin O. Smith, Jan Stary, Irina Stasevich, Sabine Strehl, Takashi Taga, Daisuke Tomizawa, David Webb, Zuzana Zemanova, C. Michel Zwaan, and Marry M. van den Heuvel-Eibrink
Blood 2009; 114: 2489-2496.
[Abstract]
[Full text]
[PDF]
Minimal residual disease levels assessed by NPM1 mutation–specific RQ-PCR provide important prognostic information in AML
- Susanne Schnittger, Wolfgang Kern, Claudia Tschulik, Tamara Weiss, Frank Dicker, Brunangelo Falini, Claudia Haferlach, and Torsten Haferlach
Blood 2009; 114: 2220-2231.
[Abstract]
[Full text]
[PDF]
Chronic myeloid leukemia (CML) with P190BCR-ABL: analysis of characteristics, outcomes, and prognostic significance
- Dushyant Verma, Hagop M. Kantarjian, Dan Jones, Rajyalakshmi Luthra, Gautam Borthakur, Srdan Verstovsek, Mary Beth Rios, and Jorge Cortes
Blood 2009; 114: 2232-2235.
[Abstract]
[Full text]
[PDF]
A lower risk of recurrent venous thrombosis in women compared with men is explained by sex-specific risk factors at time of first venous thrombosis in thrombophilic families
- Willem M. Lijfering, Nic J. G. M. Veeger, Saskia Middeldorp, Karly Hamulyák, Martin H. Prins, Harry R. Büller, and Jan van der Meer
Blood 2009; 114: 2031-2036.
[Abstract]
[Full text]
[PDF]
Long-term outcome of patients with chronic myeloid leukemia treated with second-generation tyrosine kinase inhibitors after imatinib failure is predicted by the in vitro sensitivity of BCR-ABL kinase domain mutations
- Elias Jabbour, Daniel Jones, Hagop M. Kantarjian, Susan O'Brien, Constantine Tam, Charles Koller, Jan A. Burger, Gautam Borthakur, William G. Wierda, and Jorge Cortes
Blood 2009; 114: 2037-2043.
[Abstract]
[Full text]
[PDF]
Improving survival in patients with chronic lymphocytic leukemia (1980-2008): the Hospital Clínic of Barcelona experience
- Pau Abrisqueta, Arturo Pereira, Ciril Rozman, Marta Aymerich, Eva Giné, Carol Moreno, Ana Muntañola, María Rozman, Neus Villamor, Kate Hodgson, Elías Campo, Francesc Bosch, and Emili Montserrat
Blood 2009; 114: 2044-2050.
[Abstract]
[Full text]
[PDF]
A risk-adapted, response-based approach using ABVE-PC for children and adolescents with intermediate- and high-risk Hodgkin lymphoma: the results of P9425
- Cindy L. Schwartz, Louis S. Constine, Doojduen Villaluna, Wendy B. London, Robert E. Hutchison, Richard Sposto, Steven E. Lipshultz, Charles S. Turner, Pedro A. deAlarcon, and Allen Chauvenet
Blood 2009; 114: 2051-2059.
[Abstract]
[Full text]
[PDF]
Allogeneic hematopoietic stem cell transplantation in children and adolescents with recurrent and refractory Hodgkin lymphoma: an analysis of the European Group for Blood and Marrow Transplantation
- Alexander Claviez, Carme Canals, Daan Dierickx, Jerry Stein, Isabel Badell, Andrea Pession, Stephen Mackinnon, Shimon Slavin, Jean-Hugues Dalle, Manuel Jurado Chacón, Mahmoud Sarhan, Robert Francis Wynn, Meinolf Suttorp, Giorgio Dini, Anna Sureda, and Norbert Schmitz, on behalf of the Lymphoma and Pediatric Diseases Working Parties
Blood 2009; 114: 2060-2067.
[Abstract]
[Full text]
[PDF]
|
|
